DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Jeff Bezos - 4 Sam Altman - 3 he's - 2 Bezos - 2 Peter Thiel - 2 Elon Musk - 1 Mark Zuckerberg - 1 Altman - 1
Top related locs:
geroscience Silicon Valley OpenAI's San Francisco Meta Golden City Retro.bio Redwood City , California San Diego
Top related orgs:
Altos Labs - 3 Biosciences - 2 Business - 1 OpenAI - 1 Harvard - 1 MIT - 1 Caltech - 1 Extension - 1

Search resuls for: "Altos Labs"


8 mentions found


☆ Sam Altman's mission to increase human lifespan with a $180 million shipping container experiment at Retro Biosciences
  + stars: | 2024-03-23 | by ( Hilary Brueck | ) www.businessinsider.com   time to read: +11 min
Called Retro Biosciences, the startup's goal is simple yet supremely ambitious: Add 10 healthy, enjoyable years onto the back end of our lifetimes. But Retro Biosciences actually fits quite neatly into Altman's futuristic worldview. Retro BiosciencesRetro Biosciences sits about 30 miles south of OpenAI's San Francisco headquarters, where ChatGPT was hatched. Joe Betts-LaCroix is the CEO of Retro Biosciences. There are things we already know work super well to improve human longevity, like exercise, diet, faith, and social support.
Persons: Sam Altman, he's, Elon Musk, Mark Zuckerberg, Altman, Instacart —, Joe Betts, LaCroix, isn't, Betts, Retro's, spry, Yamanaka, Shinya Yamanaka, it's, they've, Sora, Thiel, Jeff Bezos, Bezos, Yuri Milner, Billionaire Peter Thiel, He's, Aubrey de Grey, Christian Angermayer, biogerontologist Daniel Promislow, Altman's, Matt Buckley Organizations: Business, OpenAI, Biosciences, Harvard, MIT, Caltech, Extension, Apple, Stanford University, Retro, Bezos, Labs, Billionaire, Cambrian, Retro Biosciences, Bloomberg Locations: geroscience, Silicon Valley, OpenAI's San Francisco, Meta, Golden City, Retro.bio, Redwood City , California, San Diego
☆ A Guide to Longevity: Diet, Fitness, Drugs, Tips
  + stars: | 2023-11-22 | by ( Business Insider | ) www.businessinsider.com   time to read: +1 min
To mature in mind alone, without the aches, pains, wrinkles, and ailments that emerge as our cells break down over time. Sam Altman, of OpenAI fame, invested $180 million in a niche startup that is trying to extend human lifespan by 10 years. Peter Thiel invested in Unity Biotechnology, which is studying senescent cells — cells that do not break down as we age. AdvertisementBusiness Insider's "Forever Young" explores the many ways we as a society are pursuing longer, healthier lives. From new drugs to supplements to lifestyle tweaks to scientific experiments, here's how scientists — and everyday people — are trying to turn back the clock on aging.
Persons: Jeff Bezos, Sam Altman, Peter Thiel Organizations: Altos Labs, Unity Biotechnology
☆ It's not just the uber-rich freezing their brains and bodies when they die. An HBO show visited a conference filled with everyday people excited to do it.
  + stars: | 2023-09-24 | by ( Kylie Kirschner | ) www.businessinsider.com   time to read: +5 min
The series finale of HBO's "How To with John Wilson" explored cryonics and the quest for immortality. Sam Altman, Jeff Bezos, Peter Thiel, and Bryan Johnson all invested in anti-aging or cryonics. Get the inside scoop on today’s biggest stories in business, from Wall Street to Silicon Valley — delivered daily. Insider has previously reported on Alcor competitor Cryonics Institute, a more affordable alternative that charges $28,000 for a body to be stored indefinitely. A Cryonics Institute model of the tanks used to store bodies, which are actually stored upside down in practice.
Persons: John Wilson, Sam Altman, Jeff Bezos, Peter Thiel, Bryan Johnson, It's, Wilson, hasn't, Bari Weiss, he's, Johnson Organizations: Service, Alcor, HBO, MIT Technology, Biosciences, Altos Labs Locations: Wall, Silicon, Altos
☆ Jeff Bezos is ripped now. Here's how the Amazon founder went from scrawny to brawny — even though he still cheats with pancakes
  + stars: | 2023-07-27 | by ( Jyoti Mann | Lakshmi Varanasi | ) www.businessinsider.com   time to read: +3 min
Amazon founder Jeff Bezos has had a "glo-up" in recent years since stepping back from the company. He went from eating a tin of biscuits for breakfast every morning to putting in hours in the gym. Jeff Bezos was a pretty scrawny guy when he founded Amazon in 1994. She said that Bezos "stole" her personal trainer, Wes Okerson, who has also trained celebrities like Tom Cruise and Gerard Butler. Beyond his personal diet and fitness regimen Bezos has reportedly also invested in anti-aging research company Altos Labs.
Persons: Jeff Bezos, Lauren Sanchez, Sanchez, Wes Okerson, Tom Cruise, Gerard Butler, Jeff, Bezos, Bezos's, MacKenzie Scott, Betty Crocker Organizations: Amazon, Wall Street, Pillsbury, Altos Labs
☆ Humans can't live forever, but we haven't even come close to the limit for how long our bodies could last
  + stars: | 2023-04-19 | by ( Emily Swaim | ) www.businessinsider.com   time to read: +10 min
Mysteries like cellular senescence, telomere length, and DNA methylation hold the keys to our longevity. But so far, no one has figured out how to completely prevent or eliminate harmful senescent cells. DNA methylation is linked to several age-related diseasesTreating or preventing age-related diseases is one of the keys to unlocking longer, healthier lives. Similar to telomeres, DNA methylation is another way scientists can measure your biological age to help predict your life expectancy. For example, telomere shortening can lead to DNA damage, which in turn disrupts your mitochondria.
☆ How GSK plans to replenish its depleted medicine cabinet
  + stars: | 2023-03-15 | by ( Maggie Fick | ) www.reuters.com   time to read: +6 min
GSK has since suffered a series of clinical trial setbacks in its cancer drugs portfolio, most recently last year involving ovarian cancer drug Zejula and blood cancer drug Blenrep. BLOCKBUSTER POTENTIALAnalysts say that despite a string of strong quarterly earnings, lingering concerns over the company's drug pipeline reflect in GSK's share price. The investor said he does not see enough GSK drugs, either on the market or in development, with potential to be a so-called "blockbusters" with annual sales exceeding $1 billion. But Wood said the overhauled R&D department has put GSK in a strong position to meet growth targets. U.S. regulatory approval on GSK's vaccine, and a rival vaccine developed by Pfizer, is expected in May.
☆ OpenAI's 37-year-old CEO bet $180 million on a little-known biotech startup that's trying to help people live 10 years longer
  + stars: | 2023-03-09 | by ( Yeji Jesse Lee | ) www.businessinsider.com   time to read: +3 min
According to a report by MIT Technology Review, OpenAI CEO Sam Altman is among the group. Altman has quietly funded a longevity startup with $180 million, MIT Technology Review said. The latest addition to the group is Sam Altman, the 37-year-old CEO of the red-hot AI startup OpenAI. Altman quietly backed a mysterious longevity startup called Retro Biosciences with $180 million of his own funds, according to a report in MIT Technology Review. "The main thing for Retro is to be a really good bio startup, because that is a rare thing," Altman told MIT Technology Review.
☆ A former Harvard chemist just raised $178 million for a biotech startup that plans to treat previously untreatable cancers
  + stars: | 2022-11-21 | by ( Andrew Dunn | ) www.businessinsider.com   time to read: +6 min
The biotech FogPharma has raised $178 million in a Series D round. The longtime Harvard chemist Greg Verdine founded Fog to tackle "undruggable" cancers. Fog's drugs, known as polypeptides or short fragments of proteins, blur the line between small molecules and biologics, sharing characteristics of both types of medicines. Verdine calls it "the magic structure" for Fog's drugs. "I thought he'd be able to find things that bind, but I was very skeptical that he could turn them into drugs," Klausner told Insider.
0 next >>
Total: 8